BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4021726)

  • 41. Effects of cycloheximide and tunicamycin on cell surface expression of pancreatic muscarinic acetylcholine receptors.
    Hootman SR; Verme TB; Habara Y
    FEBS Lett; 1990 Nov; 274(1-2):35-8. PubMed ID: 2253779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Muscarinic cholinergic receptors: autoradiographic localization of high and low affinity agonist binding sites.
    Wamsley JK; Zarbin MA; Birdsall NJ; Kuhar MJ
    Brain Res; 1980 Oct; 200(1):1-12. PubMed ID: 7417800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agonist-induced changes in the modulation of K+ permeability and beating rate by muscarinic agonists in cultured heart cells.
    Galper JB; Dziekan LC; Miura DS; Smith TW
    J Gen Physiol; 1982 Aug; 80(2):231-56. PubMed ID: 7119731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor.
    Wess J; Nanavati S; Vogel Z; Maggio R
    EMBO J; 1993 Jan; 12(1):331-8. PubMed ID: 7679072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence that hyperglycemia increases muscarinic binding in pancreatic islets of the rat.
    Ostenson CG; Grill V
    Endocrinology; 1987 Nov; 121(5):1705-10. PubMed ID: 3311716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Muscarinic M1, M2 receptor binding. Relationship with functional efficacy.
    Freedman SB; Beer MS; Harley EA
    Eur J Pharmacol; 1988 Oct; 156(1):133-42. PubMed ID: 3208836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptors.
    Waelbroeck M; Camus J; Winand J; Christophe J
    Life Sci; 1987 Nov; 41(19):2235-40. PubMed ID: 3118122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SDZ ENS 163 a novel pilocarpine like drug: pharmacological in vitro and in vivo profile.
    Enz A; Boddeke H; Sauter A; Rudin M; Shapiro G
    Life Sci; 1993; 52(5-6):513-20. PubMed ID: 8382766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors.
    Maggio R; Vogel Z; Wess J
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):3103-7. PubMed ID: 8385357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of pH on muscarinic acetylcholine receptors from rat brainstem.
    Anthony BL; Aronstam RS
    J Neurochem; 1986 Feb; 46(2):556-61. PubMed ID: 3079819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of agonist-induced down-regulation and subsequent recovery of muscarinic acetylcholine receptors in a clonal neuroblastoma x glioma hybrid cell line.
    Ray P; Middleton W; Berman JD
    J Neurochem; 1989 Feb; 52(2):402-9. PubMed ID: 2562988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aprophit: an irreversible antagonist for muscarinic receptors.
    Newman AH; Covington J; Oleshansky M; Jackson BW; Weissman BA; Leader H; Chiang PK
    Biochem Pharmacol; 1990 Sep; 40(6):1357-64. PubMed ID: 2403389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
    Dickinson KE; Matsumoto H; Anderson W; Pruitt RE; Uemura N; Hirschowitz BI
    J Pharmacol Exp Ther; 1988 Sep; 246(3):879-86. PubMed ID: 2901489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of rat pancreatic amylase secretion and muscarinic receptor populations by chronic bethanechol treatment.
    Larose L; Poirier GG; Dumont Y; Fregeau C; Blanchard L; Morisset J
    Eur J Pharmacol; 1983 Nov; 95(3-4):215-23. PubMed ID: 6197311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of ventricular M2 muscarinic receptors in cardiomyopathic hamster (CHF 147) at the necrotic stage of the myopathy.
    Wilkinson M; Horackova M; Giles A
    Pflugers Arch; 1994 Apr; 426(6):516-23. PubMed ID: 8052521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impairment of muscarinic stimulation of adenylyl cyclase by heparin in rat olfactory bulb.
    Olianas MC; Onali P
    Life Sci; 1997; 61(5):515-22. PubMed ID: 9247321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture.
    Aronstam RS; Ryan US; Catravas JD
    Pharmacology; 1992; 44(6):324-33. PubMed ID: 1508962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term disappearance of muscarinic cell surface receptors in carbachol-induced desensitization.
    Maloteaux JM; Gossuin A; Pauwels PJ; Laduron PM
    FEBS Lett; 1983 May; 156(1):103-7. PubMed ID: 6852245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thermodynamics of antagonist binding to rat muscarinic M2 receptors: antimuscarinics of the pridinol, sila-pridinol, diphenidol and sila-diphenidol type.
    Waelbroeck M; Camus J; Tastenoy M; Lambrecht G; Mutschler E; Kropfgans M; Sperlich J; Wiesenberger F; Tacke R; Christophe J
    Br J Pharmacol; 1993 Jun; 109(2):360-70. PubMed ID: 8102927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Charge but not chemical class explains the selective binding of [3H]N-methylscopolamine to a subpopulation of [3H]quinuclidinyl benzilate binding sites in rat cerebral cortex homogenates.
    Lee NH; Ramkumar V; el-Fakahany EE
    Eur J Pharmacol; 1986 Oct; 130(1-2):153-5. PubMed ID: 3780857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.